Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2024

Aug 13, 2024

32227_dirs_2024-08-13_8c8905b7-60b4-45f2-a3fb-23de56626094.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2024-08-10

Reporting Person: Zook Anthony P. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-08-10 Common Stock M 11336 Acquired 11336 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-08-10 Restricted Stock Unit $0 M 11336 Disposed Common Stock (11336) Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $14.82 2033-08-10 Common Stock (8353) 8353 Direct
Stock Option (Right to Buy) $13.71 2034-06-01 Common Stock (8672) 8672 Direct
Restricted Stock Unit $0 Common Stock (12254) 12254 Direct

Footnotes

F1: Reflects release of restricted stock units that were previously reported on a Form 4.

F2: Once vested, the shares of common stock are not subject to expiration.